Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
about
FLT3 inhibitors in the treatment of acute myeloid leukemia: the start of an era?Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib.The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care.The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyComorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML)How I assess comorbidities before hematopoietic cell transplantationGeriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemiaAcute myeloid leukaemia: optimal management and recent developments.To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century.Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.Acute myeloid leukemia and myelodysplastic syndromes in older adults.Elderly acute myeloid leukemia: assessing risk.Emerging strategies for the treatment of older patients with acute myeloid leukemia.Definition of Unfit for Standard Acute Myeloid Leukemia Therapy.Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study.Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities.The management and treatment of acute leukemias in the elderly population.Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia.
P2860
Q35048217-3AFF696A-DDE2-4903-A9E5-09763C1C74FEQ35265868-BF0D6B3B-E1C7-4983-9F95-2F87199EA7F6Q35601183-26F31A3F-3C14-4D01-B572-BA4B93330B61Q35832484-EE1A4324-5560-4CDB-BDA5-9ECEAB7C0809Q35882830-D4BB9D3C-9E95-414F-938F-1C934EA97A1EQ36563582-7986FCFA-E4DA-4C1C-B78E-0FC6EAD4FFBFQ36761518-8327BC3C-391F-4BC6-A955-2535E9C36110Q36873270-B7D54FEA-1A7C-4C94-BA5F-A4550A4B272DQ36914091-08ED03F0-55E9-46F5-9A48-969D53FE6C82Q38104287-178DE161-0AED-4FDE-B1E4-8F118C3ADF0DQ38183943-4A9E6ACE-42BB-49D8-BC70-9D78600CE4EEQ38234863-0BB0F130-C355-43F1-A8B5-3261B1260740Q38458166-6FD0D2A4-1052-430D-9EFF-ACACA8842550Q38818726-0CB93EAB-A461-42CF-AC39-F960A3DDDDA4Q38967020-4545D5B8-610E-4A31-B65A-1D835350AD84Q39483755-BF45925F-883D-42DD-ABA0-AE58E0B35718Q40519438-558C7C17-984F-4833-859D-C23D3CBD903EQ44000070-912DEFB9-103C-473B-BEEB-200CCC6193C6Q45206762-D1EF285D-72F3-454F-B777-434F4502C2BCQ49987424-BD458AA0-9DA3-450C-9D4B-2B09498FACEFQ53164864-6983F6E1-7C1B-404A-9031-5902B31D9E66
P2860
Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@en
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@nl
type
label
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@en
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@nl
prefLabel
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@en
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@nl
P2093
P50
P356
P1476
Comorbidities and FLT3-ITD abn ...... te myeloid leukaemia patients.
@en
P2093
Angela Rago
Anna Guarini
Anna Maria Frustaci
Caterina Stefanizzi
Claudio Cartoni
Daniela Diverio
Giuseppe Cimino
Laura Cannella
Mauro Nanni
P304
P356
10.1002/HON.889
P577
2009-09-01T00:00:00Z